Find innovation and industry collaboration at UOW.
Consistently ranked in the top 2% of universities worldwide, the University of Wollongong (UOW) has earned its place through world-class research and teaching. The university generates $2.2 billion in output annually, whilst being home to a well-developed innovation ecosystem that supports industry collaboration and excellence.
The University of Wollongong’s commitment to industry collaboration is reflected via its award-winning research and technology precinct, the Innovation Campus. The $600 million site is home to various organisations that work alongside a number of research institutes and is growing, with the next phase of development focused on the creation of a Health and Wellbeing precinct. The Innovation Campus is also home to well-known businesses including NEC Australia, Komatsu and AMP Advice.
iAccelerate, the region’s first business incubator and accelerator, is also located on the Innovation Campus. Opening in July 2016 with space for 280 entrepreneurs, iAccelerate is built around a robust educational program, formalised business acceleration monitoring and one-to-one mentoring. A total of 57 start-up companies have been supported by iAccelerate to date, with a range of product offerings including 3D printers, software programs, geomapping tools and social enterprise initiatives - to name just a few. iAccelerate accept applications for new businesses periodically throughout the year, with the latest round of applications currently being assessed.
An international centre of research excellence that ranks in the top 1% for research quality, UOW is home to five major research institutes with a variety of disciplines including building, materials, health, medical and early childhood. With a view to provide real world solutions to real world problems, UOW has a strong focus on innovation and commercialisation. Major projects currently being undertaken include:
Improving sexual health in the developing world: Biomedical engineer and Associate Professor Robert Gorkin from the Australian Institute for Innovative Materials is leading a research team that is working to develop their hydrogel condom for commercialisation. Currently in preliminary trials, the next generation condom is designed to provide better sensation and encourage increased use in the developing world, with the team securing funding from the Bill & Melinda Gates Foundation to help develop a market-ready product.
Reducing the spread of bacteria: Researchers at the University of Wollongong, led ARC Research Hub for Australian Steel Manufacturing, have been investigating self-cleaning, anti-microbial organic coatings for painted sheet steel. The coating helps to prevent mould, algae and other bacteria, and is especially useful in humid environments. Not only is the coating more effective than what is currently available in the market, but it also more environmentally friendly and prevents micro-organisms from attaching in the first place. Businesses in the marine industry and hospitals in particular will reap significant benefits when commercially available.
Developing more effective and less toxic chemotherapy drugs: Leading Wollongong oncologist Professor Philip Clingan is the co-inventor of a new chemotherapy drug that has proved successful in its first human trials in Wollongong. Initially designed in a laboratory at the University of Wollongong over a decade ago, a recent 18 month clinical trial of the drug saw positive results for participants, with increased doses being administered causing no additional increase in side effects and toxicity. The reduction of adverse outcomes has the potential to benefits individuals and communities alike.